Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

LivaNova

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$22M
Portfolio companies 5
Rounds per year 0.14
Lead investments 0
Key employees Soon

Areas of investment

  • Medical Device
  • Health Care
  • Medical
  • Specialized Finance
  • Consulting Services (B2B)
Summary

LivaNova appeared to be the Corporate Investor, which was created in 1987. The venture was found in Europe in United Kingdom. The main office of represented Corporate Investor is situated in the London.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually.

The standard case for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Sofinnova Partners, UCB Pharma, U.S. Venture Partners (USVP). In the next rounds fund is usually obtained by Venture Partners, Sofinnova Partners, Sectoral Asset Management.

The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight HighLife, MD Start, ShiraTronics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Medical, Manufacturing.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of LivaNova:
Typical Co-investors
LivaNova is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after LivaNova:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Caxton Advantage Life Sciences Fund New York, New York, United States
Five Arrows Principal Investments France, Ile-de-France, Paris
Gofar Holdings China, Guangdong, Guangzhou
Hunan Zhongai Social Impact Investment China, Fujian, Hunan
Hydrogen Capital Partners Luxembourg, Luxembourg
Noventi Ventures -
Owl Ventures California, San Francisco, United States
RCM Business Bhilwara, India, Rajasthan
Singh Capital Partners Maryland, Potomac, United States
Steelpoint Capital Partners California, Solana Beach, United States
Sud Angels France, Languedoc-Roussillon, Montpellier
UnityVC Beijing, Beijing, China
West Elk Partners -
WRD Capital -
Yahui Precision Medicine Fund China, Yunnan, Zhaotong

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Noctrix Health

Health Care
Medical Device
Therapeutics
$17M11 Jan 2021 San Francisco, California, United States

ShiraTronics

Clinical Trials
Health Care
Medical Device
$33M24 Oct 2019 Minneapolis, Minnesota, United States

Ceribell

Biotechnology
Health Care
Health Diagnostics
Medical Device
$35M25 Sep 2018 Mountain View, California, United States

HighLife

Health Care
Medical
Medical Device
$14M30 Oct 2017 Ile-de-France

MD Start

Consulting Services (B2B)
Medical
Medical Device
Other Commercial Services
Specialized Finance
$11M14 Oct 2016 Paris, Ile-de-France, France

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent LivaNova?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: